Cargando…
MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation
Myocyte enhancer factor 2B (MEF2B) is a transcription factor with mutation hotspots at K4, Y69 and D83 in diffuse large B-cell lymphoma (DLBCL). To provide insight into the regulatory network of MEF2B, in this study, we analyse global gene expression and DNA-binding patterns. We find that candidate...
Autores principales: | Pon, Julia R., Wong, Jackson, Saberi, Saeed, Alder, Olivia, Moksa, Michelle, Grace Cheng, S. -W., Morin, Gregg B., Hoodless, Pamela A., Hirst, Martin, Marra, Marco A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918335/ https://www.ncbi.nlm.nih.gov/pubmed/26245647 http://dx.doi.org/10.1038/ncomms8953 |
Ejemplares similares
-
MEF2 transcription factors: developmental regulators and emerging cancer genes
por: Pon, Julia R., et al.
Publicado: (2015) -
Distinct functions of alternatively spliced isoforms encoded by zebrafish mef2ca and mef2cb
por: Ganassi, M., et al.
Publicado: (2014) -
MEF2 signaling and human diseases
por: Chen, Xiao, et al.
Publicado: (2017) -
MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma
por: Torabi, Alireza, et al.
Publicado: (2023) -
Mef2A, a homologue of animal Mef2 transcription factors, regulates cell differentiation in Dictyostelium discoideum
por: Galardi-Castilla, María, et al.
Publicado: (2013)